Calypso Biotech Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
12
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$425M
Calypso Biotech General Information
Description
Developer of monoclonal antibodies designed to provide treatment of immune pathologies with large unmet medical needs. The company's platform discovers and develops novel therapies for auto-immune diseases by controlling homeostasis, enabling patients suffering from severe gastrointestinal diseases such as gastric and pancreatic cancer to begin treatment and result in a higher likelihood of successful treatment.
Contact Information
Website
www.calypsobiotech.comCorporate Office
- Chemin des Aulx 14
- Plan-les-Ouates
- 1228 Geneva
- Switzerland
Corporate Office
- Chemin des Aulx 14
- Plan-les-Ouates
- 1228 Geneva
- Switzerland
Calypso Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 07-Jan-2024 | $425M | Completed | Generating Revenue | ||
| 6. Later Stage VC | 28-Apr-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 20-Feb-2019 | Completed | Generating Revenue | |||
| 4. Seed Round | Completed | Startup | ||||
| 3. Accelerator/Incubator | 01-Mar-2018 | Completed | Startup | |||
| 2. Grant | 01-Apr-2015 | $190K | $3.32M | Completed | Startup | |
| 1. Seed Round | 04-Mar-2013 | $3.32M | $3.32M | Completed | Startup |
Calypso Biotech Comparisons
Industry
Financing
Details
Calypso Biotech Competitors (42)
One of Calypso Biotech’s 42 competitors is NorthSea Therapeutics, a Venture Capital-Backed company based in Amsterdam, Netherlands.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NorthSea Therapeutics | Venture Capital-Backed | Amsterdam, Netherlands | ||||
| Baliopharm | Venture Capital-Backed | Basel, Switzerland | ||||
| Centrose | Venture Capital-Backed | Madison, WI | ||||
| Actitrexx | Venture Capital-Backed | Mainz, Germany | ||||
| Topas Therapeutics | Venture Capital-Backed | Hamburg, Germany |
Calypso Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Calypso Biotech Patents
Calypso Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024028448-A1 | Il-15 inhibitors useful for the treatment of atopic dermatitis | Inactive | 04-Aug-2022 | ||
| AU-2015303183-A1 | Antibodies specific for mmp9 | Active | 13-Aug-2014 | ||
| AU-2015303183-B2 | Antibodies specific for mmp9 | Inactive | 13-Aug-2014 | ||
| CA-2956986-A1 | Antibodies specific for mmp9 | Inactive | 13-Aug-2014 | ||
| EP-2985295-A1 | Antibodies specific for mmp9 | Inactive | 13-Aug-2014 | C07K16/40 |
Calypso Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Calypso Biotech Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Fountain Healthcare Partners | Venture Capital | Minority | ||
| Gilde Healthcare | PE/Buyout | Minority | ||
| Inkef | Venture Capital | Minority | ||
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | |||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority |
Calypso Biotech FAQs
-
When was Calypso Biotech founded?
Calypso Biotech was founded in 2013.
-
Where is Calypso Biotech headquartered?
Calypso Biotech is headquartered in Geneva, Switzerland.
-
What is the size of Calypso Biotech?
Calypso Biotech has 12 total employees.
-
What industry is Calypso Biotech in?
Calypso Biotech’s primary industry is Drug Discovery.
-
Is Calypso Biotech a private or public company?
Calypso Biotech is a Private company.
-
What is the current valuation of Calypso Biotech?
The current valuation of Calypso Biotech is .
-
What is Calypso Biotech’s current revenue?
The current revenue for Calypso Biotech is .
-
How much funding has Calypso Biotech raised over time?
Calypso Biotech has raised $35.6M.
-
Who are Calypso Biotech’s investors?
Fountain Healthcare Partners, Gilde Healthcare, Inkef, Johnson & Johnson Innovation - JLABS, and Johnson & Johnson JJDC are 5 of 7 investors who have invested in Calypso Biotech.
-
Who are Calypso Biotech’s competitors?
NorthSea Therapeutics, Baliopharm, Centrose, Actitrexx, and Topas Therapeutics are some of the 42 competitors of Calypso Biotech.
-
When was Calypso Biotech acquired?
Calypso Biotech was acquired on 07-Jan-2024.
-
Who acquired Calypso Biotech?
Calypso Biotech was acquired by Novartis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
